Beusch Christian M, Braesch-Andersen Ken, Felldin Ulrika, Sabatier Pierre, Widgren Anna, Bergquist Jonas, Grinnemo Karl-Henrik, Rodin Sergey
Cardio-Thoracic Translational Medicine (CTTM) Lab, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
Commun Biol. 2025 Jan 17;8(1):78. doi: 10.1038/s42003-025-07515-z.
Recent developments in mass spectrometry-based proteomics have established it as a robust tool for system-wide analyses essential for pathophysiological research. While post-mortem samples are a critical source for these studies, our understanding of how body decomposition influences the proteome remains limited. Here, we have revisited published data and conducted a clinically relevant time-course experiment in mice, revealing organ-specific proteome regulation after death, with only a fraction of these changes linked to protein autolysis. The liver and spleen exhibit significant proteomic alterations within hours post-mortem, whereas the heart displays only modest changes. Additionally, subcellular compartmentalization leads to an unexpected surge in proteome alterations at the earliest post-mortem interval (PMI). Additionally, we have conducted a comprehensive analysis of semi-tryptic peptides, revealing distinct consensus motifs for different organs, indicating organ-specific post-mortem protease activity. In conclusion, our findings emphasize the critical importance of considering PMI effects when designing proteomics studies, as these effects may significantly overshadow the impacts of diseases. Preferably, the samples should be taken in the operation room, especially for studies including subcellular compartmentalization or trans-organ comparison. In single-organ studies, the planning should involve careful control of PMI.
基于质谱的蛋白质组学的最新进展已使其成为病理生理学研究中进行全系统分析的强大工具。虽然死后样本是这些研究的关键来源,但我们对尸体分解如何影响蛋白质组的了解仍然有限。在这里,我们重新审视了已发表的数据,并在小鼠身上进行了一项具有临床相关性的时间进程实验,揭示了死后器官特异性蛋白质组调控,其中只有一小部分变化与蛋白质自溶有关。肝脏和脾脏在死后数小时内表现出显著的蛋白质组学改变,而心脏仅表现出适度的变化。此外,亚细胞区室化导致死后最早间隔期(PMI)蛋白质组改变意外激增。此外,我们对半胰蛋白酶肽进行了全面分析,揭示了不同器官的独特共有基序,表明存在器官特异性的死后蛋白酶活性。总之,我们的研究结果强调了在设计蛋白质组学研究时考虑PMI效应的至关重要性,因为这些效应可能会显著掩盖疾病的影响。最好在手术室采集样本,特别是对于包括亚细胞区室化或跨器官比较的研究。在单器官研究中,计划应包括对PMI的仔细控制。